The United States still has enormous oil resources, record production, and a functioning emergency stockpile. But softer prices, thinning refinery capacity, lower proved reserves, and a leaner Strategic Petroleum Reserve are creating a more fragile energy picture than the headline numbers suggest.
Microsoft and Mayo Clinic say their new healthcare AI model could reshape how patients and clinicians communicate. The promise is not a robot physician, but a powerful medical intelligence system designed to make conversations with doctors faster, clearer, and more personalized.
Anthropic’s confidential IPO filing has turned a private AI arms race into a public market story with trillion-dollar implications. Investors are now weighing whether Claude’s maker can justify one of the boldest valuations Wall Street has ever seen.
New research has intensified concern over a rare but serious eye condition linked to semaglutide drugs, with one 2026 analysis finding a much stronger signal for Wegovy than Ozempic. As lawsuits begin to build, patients and doctors are confronting a difficult question: how should a very rare risk be weighed against major benefits in obesity and diabetes care?
The tech industry’s layoff cycle has accelerated again, with roughly 142,000 workers losing their jobs in 2026 and a fresh batch of companies adding to the toll. Behind the headlines is a deeper story about AI spending, efficiency pressures, and a labor market being reshaped in real time.
The United States still has enormous oil resources, record production, and a functioning emergency stockpile. But softer prices, thinning refinery capacity, lower proved reserves, and a leaner Strategic Petroleum Reserve are creating a more fragile energy picture than the headline numbers suggest.
Microsoft and Mayo Clinic say their new healthcare AI model could reshape how patients and clinicians communicate. The promise is not a robot physician, but a powerful medical intelligence system designed to make conversations with doctors faster, clearer, and more personalized.
Anthropic’s confidential IPO filing has turned a private AI arms race into a public market story with trillion-dollar implications. Investors are now weighing whether Claude’s maker can justify one of the boldest valuations Wall Street has ever seen.
New research has intensified concern over a rare but serious eye condition linked to semaglutide drugs, with one 2026 analysis finding a much stronger signal for Wegovy than Ozempic. As lawsuits begin to build, patients and doctors are confronting a difficult question: how should a very rare risk be weighed against major benefits in obesity and diabetes care?
The tech industry’s layoff cycle has accelerated again, with roughly 142,000 workers losing their jobs in 2026 and a fresh batch of companies adding to the toll. Behind the headlines is a deeper story about AI spending, efficiency pressures, and a labor market being reshaped in real time.
The United States still has enormous oil resources, record production, and a functioning emergency stockpile. But softer prices, thinning refinery capacity, lower proved reserves, and a leaner Strategic Petroleum Reserve are creating a more fragile energy picture than the headline numbers suggest.
Microsoft and Mayo Clinic say their new healthcare AI model could reshape how patients and clinicians communicate. The promise is not a robot physician, but a powerful medical intelligence system designed to make conversations with doctors faster, clearer, and more personalized.
Anthropic’s confidential IPO filing has turned a private AI arms race into a public market story with trillion-dollar implications. Investors are now weighing whether Claude’s maker can justify one of the boldest valuations Wall Street has ever seen.
New research has intensified concern over a rare but serious eye condition linked to semaglutide drugs, with one 2026 analysis finding a much stronger signal for Wegovy than Ozempic. As lawsuits begin to build, patients and doctors are confronting a difficult question: how should a very rare risk be weighed against major benefits in obesity and diabetes care?
The tech industry’s layoff cycle has accelerated again, with roughly 142,000 workers losing their jobs in 2026 and a fresh batch of companies adding to the toll. Behind the headlines is a deeper story about AI spending, efficiency pressures, and a labor market being reshaped in real time.
The United States still has enormous oil resources, record production, and a functioning emergency stockpile. But softer prices, thinning refinery capacity, lower proved reserves, and a leaner Strategic Petroleum Reserve are creating a more fragile energy picture than the headline numbers suggest.
Microsoft and Mayo Clinic say their new healthcare AI model could reshape how patients and clinicians communicate. The promise is not a robot physician, but a powerful medical intelligence system designed to make conversations with doctors faster, clearer, and more personalized.
Anthropic’s confidential IPO filing has turned a private AI arms race into a public market story with trillion-dollar implications. Investors are now weighing whether Claude’s maker can justify one of the boldest valuations Wall Street has ever seen.
New research has intensified concern over a rare but serious eye condition linked to semaglutide drugs, with one 2026 analysis finding a much stronger signal for Wegovy than Ozempic. As lawsuits begin to build, patients and doctors are confronting a difficult question: how should a very rare risk be weighed against major benefits in obesity and diabetes care?
The tech industry’s layoff cycle has accelerated again, with roughly 142,000 workers losing their jobs in 2026 and a fresh batch of companies adding to the toll. Behind the headlines is a deeper story about AI spending, efficiency pressures, and a labor market being reshaped in real time.
Microsoft and Mayo Clinic say their new healthcare AI model could reshape how patients and clinicians communicate. The promise is not a robot physician, but a powerful medical intelligence system designed to make conversations with doctors faster, clearer, and more personalized.
The United States still has enormous oil resources, record production, and a functioning emergency stockpile. But softer prices, thinning refinery capacity, lower proved reserves, and a leaner Strategic Petroleum Reserve are creating a more fragile energy picture than the headline numbers suggest.
Microsoft and Mayo Clinic say their new healthcare AI model could reshape how patients and clinicians communicate. The promise is not a robot physician, but a powerful medical intelligence system designed to make conversations with doctors faster, clearer, and more personalized.
Anthropic’s confidential IPO filing has turned a private AI arms race into a public market story with trillion-dollar implications. Investors are now weighing whether Claude’s maker can justify one of the boldest valuations Wall Street has ever seen.
New research has intensified concern over a rare but serious eye condition linked to semaglutide drugs, with one 2026 analysis finding a much stronger signal for Wegovy than Ozempic. As lawsuits begin to build, patients and doctors are confronting a difficult question: how should a very rare risk be weighed against major benefits in obesity and diabetes care?
The tech industry’s layoff cycle has accelerated again, with roughly 142,000 workers losing their jobs in 2026 and a fresh batch of companies adding to the toll. Behind the headlines is a deeper story about AI spending, efficiency pressures, and a labor market being reshaped in real time.
NOAA forecasters are signaling a dangerous early-June heat event for parts of the Midwest, Great Lakes, and Mississippi and Ohio valleys. The unusual timing matters as much as the temperature itself, because early-season heat often catches people, cities, and critical systems unprepared.
The National Hurricane Center is closely monitoring a disturbance well southwest of Baja California that now carries a 90 percent chance of tropical development this week. Forecasters say the system is likely to organize over open water, marking one of the first notable Eastern Pacific threats of the 2026 season.
The World Meteorological Organization says El Niño conditions are developing again, raising the risk of hotter temperatures and disruptive weather around the world. That warning is not just about climate science; it is a call for governments, businesses, and households to get ready before impacts intensify.
Homeownership remains elusive for millions of Americans as high prices, elevated mortgage rates, limited inventory, and widening wealth gaps reinforce one another. Even as some indicators have stabilized, the structural barriers keeping first-time buyers out of the market remain firmly in place.
The restart of federal student loan collections marks a major turning point after years of pandemic-era relief. Its effects will extend well beyond delinquent borrowers, shaping household budgets, credit markets, labor decisions, and the politics of higher education finance.
The artificial intelligence boom is not just a computing story. It is rapidly becoming an energy story, as data centers grow larger, denser, and harder for power grids to absorb without higher costs, tougher trade-offs, and new infrastructure.
The United States still has enormous oil resources, record production, and a functioning emergency stockpile. But softer prices, thinning refinery capacity, lower proved reserves, and a leaner Strategic Petroleum Reserve are creating a more fragile energy picture than the headline numbers suggest.
Microsoft and Mayo Clinic say their new healthcare AI model could reshape how patients and clinicians communicate. The promise is not a robot physician, but a powerful medical intelligence system designed to make conversations with doctors faster, clearer, and more personalized.
Anthropic’s confidential IPO filing has turned a private AI arms race into a public market story with trillion-dollar implications. Investors are now weighing whether Claude’s maker can justify one of the boldest valuations Wall Street has ever seen.
New research has intensified concern over a rare but serious eye condition linked to semaglutide drugs, with one 2026 analysis finding a much stronger signal for Wegovy than Ozempic. As lawsuits begin to build, patients and doctors are confronting a difficult question: how should a very rare risk be weighed against major benefits in obesity and diabetes care?
The tech industry’s layoff cycle has accelerated again, with roughly 142,000 workers losing their jobs in 2026 and a fresh batch of companies adding to the toll. Behind the headlines is a deeper story about AI spending, efficiency pressures, and a labor market being reshaped in real time.
NOAA forecasters are signaling a dangerous early-June heat event for parts of the Midwest, Great Lakes, and Mississippi and Ohio valleys. The unusual timing matters as much as the temperature itself, because early-season heat often catches people, cities, and critical systems unprepared.
The National Hurricane Center is closely monitoring a disturbance well southwest of Baja California that now carries a 90 percent chance of tropical development this week. Forecasters say the system is likely to organize over open water, marking one of the first notable Eastern Pacific threats of the 2026 season.
The World Meteorological Organization says El Niño conditions are developing again, raising the risk of hotter temperatures and disruptive weather around the world. That warning is not just about climate science; it is a call for governments, businesses, and households to get ready before impacts intensify.
A new New York Fed analysis argues that the rise of remote work is doing more than changing where people work. It may be making employers less willing to hire inexperienced graduates at the very moment they need their first break.
A new lawsuit argues that OpenAI failed to adequately warn families about the potential dangers ChatGPT may pose to children and teens. The case arrives as AI companies face deeper scrutiny over youth safety, mental health risks, and the limits of chatbot safeguards.
Victor Wembanyama’s first trip to the NBA Finals became one of the defining emotional moments of the 2026 playoffs. As the Spurs stunned Oklahoma City in Game 7, his visible tears and raw postgame comments gave fans, analysts, and the internet a lot to talk about.
The first baby boomers, born in 1946, are turning 80 in 2026, pushing the United States into a far more demanding phase of aging. The country has spent years preparing for retirement, but not nearly enough for what comes after: frailty, caregiving strain, housing barriers, and a long-term care system already under stress.
The United States still has enormous oil resources, record production, and a functioning emergency stockpile. But softer prices, thinning refinery capacity, lower proved reserves, and a leaner Strategic Petroleum Reserve are creating a more fragile energy picture than the headline numbers suggest.
Microsoft and Mayo Clinic say their new healthcare AI model could reshape how patients and clinicians communicate. The promise is not a robot physician, but a powerful medical intelligence system designed to make conversations with doctors faster, clearer, and more personalized.
Anthropic’s confidential IPO filing has turned a private AI arms race into a public market story with trillion-dollar implications. Investors are now weighing whether Claude’s maker can justify one of the boldest valuations Wall Street has ever seen.